These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8697677)

  • 1. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT.
    Ishii K; Mori E; Kitagaki H; Sakamoto S; Yamaji S; Imamura T; Ikejiri Y; Kono M
    Clin Nucl Med; 1996 Feb; 21(2):106-10. PubMed ID: 8697677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia].
    Tomino Y; Tachibana H; Sugita M
    Rinsho Shinkeigaku; 1994 Apr; 34(4):318-25. PubMed ID: 8026123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.
    Johnson KA; Holman BL; Rosen TJ; Nagel JS; English RJ; Growdon JH
    Arch Intern Med; 1990 Apr; 150(4):752-6. PubMed ID: 2327836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
    Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
    Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging.
    Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Masuda K
    Clin Nucl Med; 1990 Dec; 15(12):893-9. PubMed ID: 2276232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia.
    Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Ichimiya A; Masuda K
    Ann Nucl Med; 1990 Nov; 4(3):75-82. PubMed ID: 2083138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [N-isopropyl I-123 p-iodoamphetamine (IMP) brain SPECT in Alzheimer's disease].
    Momose T; Nishikawa J; Kosaka N; Ohtake T; Watanabe T; Yoshikawa K; Iio M
    Kaku Igaku; 1989 Sep; 26(9):1177-92. PubMed ID: 2810914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain spect.
    Lee BF; Liu CK; Tai CT; Chiu NT; Liu GC; Yu HS; Pai MC
    Kaohsiung J Med Sci; 2001 Aug; 17(8):394-400. PubMed ID: 11715838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of binswanger-type dementia with bilateral temporoparietal hypoperfusion in SPECT].
    Hanyu H; Sugiyama T; Abe S; Kobayashi Y; Katsunuma H; Asano T; Arai H; Takasaki M
    Kaku Igaku; 1993 Apr; 30(4):429-35. PubMed ID: 8315893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease].
    Mitsuyama Y
    Seishin Shinkeigaku Zasshi; 1989; 91(7):500-11. PubMed ID: 2608750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
    Holman BL; Johnson KA; Gerada B; Carvalho PA; Satlin A
    J Nucl Med; 1992 Feb; 33(2):181-5. PubMed ID: 1732438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of dementia with single photon emission computed tomography.
    Jagust WJ; Budinger TF; Reed BR
    Arch Neurol; 1987 Mar; 44(3):258-62. PubMed ID: 3493756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the role of 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease.
    Killen AR; Oster G; Colditz GA
    Nucl Med Commun; 1989 Apr; 10(4):271-84. PubMed ID: 2662071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
    Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
    J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 123I-iodoamphetamine.
    Tachibana H; Kawabata K; Tomino Y; Sugita M; Fukuchi M
    Dementia; 1993; 4(6):334-41. PubMed ID: 8136897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.
    Johnson KA; Mueller ST; Walshe TM; English RJ; Holman BL
    Arch Neurol; 1987 Feb; 44(2):165-8. PubMed ID: 3492992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic accuracy of single photon emission CT in Alzheimer-type dementia].
    Hanyu H; Abe S; Arai H; Asano T; Iwamoto T; Takasaki M; Suzuki T
    Nihon Ronen Igakkai Zasshi; 1992 Jun; 29(6):463-8. PubMed ID: 1527902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease in Down's syndrome with SPECT.
    Rae-Grant AD; Barbour PJ; Sirotta P; Gross P
    Clin Nucl Med; 1991 Jul; 16(7):509-10. PubMed ID: 1834388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.
    Johnson KA; Holman BL; Mueller SP; Rosen TJ; English R; Nagel JS; Growdon JH
    Arch Neurol; 1988 Apr; 45(4):392-6. PubMed ID: 3258512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
    Okamura N; Shinkawa M; Arai H; Matsui T; Nakajo K; Maruyama M; Hu XS; Sasaki H
    Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):974-8. PubMed ID: 11201187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.